Mitchell C. Shultz, MD

SAN DIEGO — In this Healio Video Perspective from the ASCRS meeting, Mitchell C. Shultz, MD, speaks about the results of the FDA clinical trial on StableVisc, a new viscoelastic agent for cataract surgery from Bausch + Lomb.

CHICAGO — In this Healio Video Perspective from the AAO meeting, Mitchell C. Shultz, MD, discusses a study that compared the iStent inject W and Hydrus microstent to treat glaucoma in patients who have and have not undergone canaloplasty.

ORLANDO — In a surgical video presentation from Cataract Surgery: Telling It Like It Is, Mitchell C. Shultz, MD, shares a technique for cataract surgery with the Bausch + Lomb Stellaris Elite platform, implanting the enVista preloaded IOL.

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.

AMELIA ISLAND, Fla. — In this video from Cataract Surgery: Telling It Like It Is, Mitchell C. Shultz, MD, explains his reasons for using the enVista toric IOL (Bausch + Lomb), including uniform power and extended depth of focus.

SAN DIEGO — At the American Society of Cataract and Refractive Surgery meeting, Mitchell C. Shultz, MD, discusses his experience beta testing Bausch + Lomb’s eyeTELLIGENCE platform with the Stellaris Elite surgical platform and how the incorporation of big data is helping him improve his performance in cataract surgery.

WASHINGTON ― At the American Society of Cataract and Refractive Surgery meeting here, Mitchell C. Shultz, MD, discusses a study showing a combination of adaptive fluidics and the use of femtosecond laser can reduce the amount of energy used in phacoemulsification.